SK bioscience Co.,Ltd. (KRX:302440)
South Korea flag South Korea · Delayed Price · Currency is KRW
48,900
-450 (-0.91%)
Last updated: Sep 9, 2025, 2:48 PM KST

SK bioscience Revenue

SK bioscience had revenue of 161.86B KRW in the quarter ending June 30, 2025, with 504.46% growth. This brings the company's revenue in the last twelve months to 534.91B, up 44.00% year-over-year. In the year 2024, SK bioscience had annual revenue of 267.55B, down -27.59%.

Revenue (ttm)
534.91B
Revenue Growth
+44.00%
P/S Ratio
7.23
Revenue / Employee
583.33M
Employees
917
Market Cap
3,867.52B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024267.55B-101.96B-27.59%
Dec 31, 2023369.51B-87.22B-19.10%
Dec 31, 2022456.73B-472.28B-50.84%
Dec 31, 2021929.00B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition